Convalescent plasma in patients receiving rituximab or ocrelizumab for multiple sclerosis or neuromyelitis Optica spectrum disorder with Covid-19:A multicenter retrospective study

被引:0
|
作者
Dequidt, Tanguy [1 ]
Richier, Quentin [2 ]
Louapre, Celine [3 ]
Ader, Florence [4 ]
Merad, Yanis [4 ]
Lauwerier, Nicolas [5 ]
Jacomet, Christine [6 ]
Carles, Michel [7 ]
Biron, Charlotte [8 ]
Gendrin, Vincent [9 ]
Marlat, Clement [10 ]
Danion, Francois [11 ]
Lepage, Tristan M. [12 ]
Sotto, Albert [13 ]
Bourdellon, Loic [14 ]
Mania, Alexandre [15 ]
Martinot, Martin [16 ]
Le Falher, Georges [17 ]
Ferre, Alexis [18 ]
Pilmis, Benoit [19 ]
Gondran, Guillaume [20 ]
Simeone, Pierre [21 ]
Henry, Matthieu [22 ]
Kamel, Toufik [23 ]
Ray, Simon [24 ]
Ancellin, Sophie [25 ]
Mele, Nicolas [26 ]
Camou, Fabrice [27 ]
Destremau, Marjolaine [27 ]
Sellenet, Jeremy [28 ]
Zucman, Noemie [29 ]
Le Marechal, Marion [30 ]
Mellouki, Khawla [31 ]
Langlois, Marie-Elodie [32 ]
Paz, David Luque [33 ]
Mousset, Maud [34 ]
Leclerc, Catherine [35 ]
Sommet, Agnes [36 ]
Lacombe, Karine [37 ]
Martin-Blondel, Guillaume [38 ,39 ]
机构
[1] Guadeloupe Univ Hosp, Dept Infect Dis, Pointe A Pitre, France
[2] Sorbonne Univ, St Antoine Hosp, Dept Infect Dis, AP HP, Paris, France
[3] Sorbonne Univ, Pitie Salpetriere Hosp, Paris Brain Inst, Dept Neurol,AP HP,CIC Neurosci, Paris, France
[4] Hosp Civils Lyon, Dept Infect Dis, Lyon, France
[5] Lille Univ Hosp, Dept Infect Dis, Lille, France
[6] Clermont Ferrand Univ Hosp, Dept Infect Dis, Clermont Ferrand, France
[7] Nice Univ Hosp, Dept Infect Dis, Nice, France
[8] Nantes Univ Hosp, Dept Infect Dis, Nantes, France
[9] Nord Franche Comte Hosp, Dept Infect Dis, Belfort, France
[10] Rouen Univ Hosp, Dept Infect Dis, Rouen, France
[11] Strasbourg Univ Hosp, Dept Infect Dis, Strasbourg, France
[12] Montpellier Univ Hosp, Dept Infect Dis, Montpellier, France
[13] Nimes Univ Hosp, Dept Infect Dis, Nimes, France
[14] Emile Durkheim Hosp, Med Unit A, Epinal, France
[15] Henri Mondor Hosp, Dept Internal Med, Aurillac, France
[16] Colmar Hosp, Dept Infect Dis, Colmar, France
[17] Beziers Hosp, Dept Internal Med, Beziers, France
[18] Versailles Hosp, Intens Care Unit, Le Chesnay, France
[19] Grp Hosp Paris St Joseph, Microbiol Unit, Antimicrobial Stewardship Team, Paris, France
[20] Limoges Univ Hosp, Dept Internal Med, Limoges, France
[21] Univ Hosp Timone, Dept Anesthesiol & Crit Care Med, AP HM, Marseille, France
[22] Dist Hosp Ctr, Med Surg Intens Care Unit, Le Roche Sur Yon, France
[23] Orleans Univ Hosp, Intens Care Unit, Orleans, France
[24] Rodez Hosp, Dept Infect Dis, Rodez, France
[25] Auch Hosp, Dept Infect Dis, Auch, France
[26] Sainte Anne Hosp, Dept Neurol, GHU Paris Psychiat & Neurosci, Paris, France
[27] Bordeaux Univ Hosp, Intens Care & Infect Dis Unit, Grp St Andre, Bordeaux, France
[28] St Jean Sud France Clin, Dept Internal Med, St Jean De Vedas, France
[29] CH Annecy Genevois, Intens Care Unit, Epagny Metz Tessy, France
[30] Univ Grenoble Alpes, Infect Dis Dept, CHU Grenoble Alpes, Grenoble, France
[31] Claude Bernard Univ Lyon 1, Valence Hosp Ctr, Dept Infect Dis, Valence, France
[32] St Joseph St Luc Hosp, Dept Internal Med & Infect Dis, Lyon, France
[33] Pontchaillou Univ Hosp, Infect Dis & Intens Care Unit, Rennes, France
[34] Comminges Pyrenees Hosp, Intens Care Unit, St Gaudens, France
[35] CHI Poissy St Germain En Laye, Dept Infect Dis, St Germain En Laye, France
[36] Toulouse Univ Hosp, Clin Invest Ctr, Toulouse, France
[37] Sorbonne Univ, St Antoine Hosp, Infect Dis Dept, IPLESP Inserm, Paris, France
[38] Toulouse Univ Hosp, Dept Infect Dis, Toulouse, France
[39] Toulouse III Univ, Toulouse Inst Infect & Inflammatory Dis, INSERM UMR1291 CNRS UMR5051, Toulouse, France
关键词
SARS-CoV-2; Protracted COVID-19; Convalescent plasma; Anti-CD20; antibodies; Multiple sclerosis; Neuromyelitis optica; THERAPY;
D O I
10.1016/j.ijid.2024.107323
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: Despite vaccination, patients receiving anti-CD20 monoclonal antibodies (mAbs) for multiple sclerosis (MS) or neuromyelitis optica spectrum disorders (NMOSD) have an increased risk of developing severe or protracted COVID-19. The aim of this study was to describe the effect of COVID-19 convalescent plasma (CCP) in patients with MS or NMOSD exposed to anti-CD20 and infected by SARS-CoV-2. Methods: This French national, retrospective cohort study was conducted between November 2020 and June 2023. Patients with MS or NMOSD, under anti-CD20 mAbs, with symptomatic COVID-19 and treated by CCP were screened. Protracted COVID-19 was defined by a duration of symptoms > 21 days. The primary endpoint was the overall survival 30 days after CCP administration. Results: Ninety-two patients from 34 hospitals were included, 84 (91%) with MS and 8 (9%) with NMOSD. Overall, 30-day survival was 97% (IC95%: 91-99). SARS-CoV-2 viremia was positive in 47/75 (61%) patients before CCP versus 9/59 (15%) seven days post-CCP. In the 52 patients (57%) with protracted COVID-19, the duration of symptoms before CCP was 51 [28-69] days, including fever in 75% of cases, which disappeared in 100% of patients 7 days post-CCP. Conclusions: CCP could be a therapeutic option in patients exposed to anti-CD20 mAbs for inflammatory demyelinating disease, particularly in those with protracted COVID-19. (c) 2024 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious This is an open access article under the CC BY license ( http://creativecommons.org/licenses/by/4.0/ )
引用
收藏
页数:9
相关论文
共 50 条
  • [31] Hospital Readmission Rates in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder Patients
    Padarti, A.
    Amod, A.
    Kilgo, W. A.
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 64 - 65
  • [32] Comparison of ocular changes in multiple sclerosis and neuromyelitis optica spectrum disorder patients
    Wang, Xiaoyue
    Bao, Li
    FRONTIERS IN NEUROLOGY, 2024, 15
  • [33] Sleep in multiple sclerosis and neuromyelitis optica spectrum disorder-the SEMN study
    Sousa, Nise Alessandra Carvalho
    de Almeida, Carlos Mauricio Oliveira
    Takano, Satiko Andrezza Ferreira
    Souza, Siane Prado Lima
    Rabelo, Ronaldo Marques Pontes
    SLEEP AND BREATHING, 2023, 27 (06) : 2453 - 2458
  • [34] Management Strategies of Patients with Neuromyelitis Optica Spectrum Disorder During the COVID-19 Pandemic Era
    Hamdy, Sherif M.
    Abdel-Naseer, Maged
    Shehata, Hatem S.
    Shalaby, Nevin M.
    Hassan, Amr
    Elmazny, Alaa
    Shaker, Ehab
    Nada, Mona A. F.
    Ahmed, Sandra M.
    Hegazy, Mohamed, I
    Mourad, Husam S.
    Abdelalim, Ahmed
    Magdy, Rehab
    Othman, Alshimaa S.
    Mekkawy, Doaa A.
    Kishk, Nirmeen A.
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2020, 16 : 759 - 767
  • [35] Recurrent hiccups in COVID-19 forme fruste of neuromyelitis optica spectrum disorder?
    Shubhakaran, Khichar P.
    JOURNAL OF FAMILY MEDICINE AND PRIMARY CARE, 2022, 11 (06) : 3388 - 3388
  • [36] Therapeutic plasma exchange for neuromyelitis optica spectrum disorder: A multicenter retrospective study by the ASFA neurologic diseases subcommittee
    Ipe, Tina S.
    Raval, Jay S.
    Fernando, Leonor P.
    Gokhale, Amit
    Jacquot, Cyril
    Johnson, Andrew D.
    Kim, Haewon C.
    Monis, Grace F.
    Mo, Yunchun D.
    Morgan, Shanna M.
    Pagano, Monica B.
    Pham, Huy P.
    Sanford, Kimberly
    Schmidt, Amy E.
    Schwartz, Joseph
    Waldman, Amy
    Webb, Jennifer
    Winters, Jeffrey L.
    Wu, Yanyun
    Yamada, Chisa
    Wong, Edward C. C.
    JOURNAL OF CLINICAL APHERESIS, 2020, 35 (01) : 25 - 32
  • [37] Clinical Features of COVID-19 on Patients With Neuromyelitis Optica Spectrum Disorders
    Apostolos-Pereira, Samira Luisa
    Campos Ferreira, Lis
    Boaventura, Mateus
    de Carvalho Sousa, Nise Alessandra
    Joca Martins, Gabriela
    d'Almeida, Jose Arthur
    Pitombeira, Milena
    Silvestre Mendes, Lucas
    Fukuda, Thiago
    Souza Cabeca, Hideraldo Luiz
    Chaves Rocha, Luciano
    Santos de Oliveira, Bianca
    Vieira Stella, Carla Renata
    Lobato de Oliveira, Enedina Maria
    de Souza Amorim, Leizian
    Ferrari de Castro, Andrea
    Pereira Gomes Neto, Antonio
    Diogo Silva, Guilherme
    Bueno, Lucas
    de Morais Machado, Maria
    Castello Dias-Carneiro, Rafael
    Maciel Dias, Ronaldo
    Porto Moreira, Alvaro
    Piccolo, Ana
    Kuntz Grzesiuk, Anderson
    Muniz, Andre
    Diniz Disserol, Caio
    Ferreira Vasconcelos, Claudia
    Kaimen-Maciel, Damacio
    Sisterolli Diniz, Denise
    Comini-Frota, Elizabeth
    Coronetti Rocha, Fernando
    Cruz dos Santos, Gutemberg Augusto
    Dadalti Fragoso, Yara
    Sciascia do Olival, Guilherme
    Ruocco, Heloisa Helena
    Siqueira, Heloise Helena
    Sato, Henry Koity
    Figueiredo, Jose Alexandre, Jr.
    Cortoni Calia, Leandro
    Teixeira Dourado, Mario Emilio, Jr.
    Scolari, Leticia
    Ribeiro Soares Neto, Herval
    Melges, Luiz
    Magno Goncalves, Marcus Vinicius
    Vellutini Pimentel, Maria Lucia
    de Castro Ribeiro, Marlise
    Gurrola Arambula, Omar
    Diniz da Gama, Paulo
    Leite Menon, Renata
    NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 2021, 8 (06):
  • [38] The effect of lowering dose of rituximab on the neuromyelitis optica spectrum disorder relapse rate during COVID-19 epidemic period
    Mehdipour, Roshanak
    Ashtari, Fereshteh
    Asgari, Mina
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2023, 455
  • [39] Clinical features of COVID-19 in patients with neuromyelitis optica spectrum disorders
    Boaventura, M.
    Apostolos-Pereira, S.
    Ferreira, L.
    Sousa, N.
    Martins, G.
    D'Almeida, J. A. C.
    Pitombeira, M.
    Mendes, L.
    Fukuda, T.
    Rocha, L.
    Cabeca, H.
    Oliveira, B.
    Vieira Stella, C.
    Oliveira, E. M.
    Amorim, L.
    Castro, A.
    Gomes Neto, P.
    Silva, G.
    Bueno, L.
    Machado, M.
    Dias-Carneiro, R. P. C.
    Dias, R.
    Moreira, A.
    Piccolo, A. C.
    Grzesiuk, A.
    Muniz, A.
    Disserol, C.
    Vasconcelos, C. C.
    Diniz, D.
    Kaimen-Maciel, D. L.
    Comini-Frota, E.
    Rocha, F.
    Sciascia Do Olival, G.
    Santos, G. A.
    Ruocco, H. H.
    Siqueira, H. H.
    Sato, H.
    Soares Neto, H.
    Figueiredo, J., Jr.
    Calia, L.
    Scolari, L.
    Melges, L. D.
    Goncalves, M. V. M.
    Pimentel, M. L.
    Dourado Junior, M. E.
    De Castro Ribeiro, M.
    Arambula, O.
    Gama, P. D.
    Menon, R.
    Thomaz, R.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 99 - 100
  • [40] The impact of the COVID-19 pandemic on hospitalizations and plasmapheresis therapy in multiple sclerosis and neuromyelitis optica spectrum disorder: a nationwide analysis from Germany
    Richter, Daniel
    Faissner, Simon
    Bartig, Dirk
    Toenges, Lars
    Hellwig, Kerstin
    Ayzenberg, Ilya
    Krogias, Christos
    Gold, Ralf
    THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2021, 14